ADVERTISEMENT
Faster Corticosteroid Tapering Safe in Relapsed/Refractory MM
06/03/2020
Ajai Chari, MD, Icahn School of Medicine, Mount Sinai, New York, NY, discusses the phase 1b PAVO study, which evaluated the safety of faster corticosteroid tapering in patients with relapsed/refractory multiple myeloma (MM) receiving subcutaneous daratumumab.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement